Zusammenfassung
Wachstumshormon (Syn. Somatotropin, somatotropes Hormon = STH, growth hormone = GH) ist ein einkettiges Peptidhormon aufgebaut aus 191 Aminosäuren (AS) ohne Zuckerreste, welches über 2 Disulfidbrücken in seine Tertiärstruktur gefaltet ist. Diese besteht aus 4 α-Helices, die antiparallel angeordnet sind. Wachstumshormon ist das Produkt des GH-1(GH-N)-Gens, welches zusammen mit Genen für humanes Chorionsomatomammotropin (hCS) und dem nur in der Plazenta exprimierten GH-2(GH-V)-Gen auf dem langen Arm des Chromosoms 17 lokalisiert ist. Neben GH mit einem Molekulargwicht von 22 kD (ca. 90%) entsteht durch alternatives Splicing eine Pro tein variante (20 kD, ca. 10%), dem die AS 32-46 der 22-kD-Form fehlen. Darüber hinaus existieren im Blut in geringeren Konzentrationen, jedoch individuell variierend, weitere GH-Varianten und Oligomere (z. B. „big“ GH) mit unterschiedlicher biologischer Aktivität. Die Expression des GH-1-Gens ist fast ausschließlich auf die somatotropen Zellen der Adenohypophyse beschränkt, welche ca. 90% ihrer Zellmasse ausmachen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Literatur zu Abschn. 7.7-7.2
Baumann G. (1991) Growth hormone heterogeneity: Genes, isohormones, variants, and binding protein. Endocrine Rev 12: 424–449
de Boer H., van der Veen E. (1997) Guidelines for optimizing growth hormone replacement therapy in adults. Horm Res 48 (Suppl 5):21–30
Frisch H. (1997) Clinical review of pediatric indications for treatment with growth hormone. In: M.B. Ranke (ed) J.A. Barth, Growth hormone over the human life span. Edition J & J, Heidelberg, pp 8–24
Moeller N. (1993) The role of growth hormone in the regulation of human fuel metabolism. In: Flyvbjerg A., Orskov H., Alberti K.G.M.M. (eds) Growth hormone and insulin-like growth factor I. Wiley, New York, pp 77–108
Ranke M.B. (1994) Growth hormone insufficiency: Clinical features, diagnosis, and therapy. In: L. DeGroot (ed) Endocrinology 3rd edn, Saunders, Philadelphia, pp 330–340
Ranke M.B., Elmlinger M. (1997) Functional role of insulin-like growth factor bin ding proteins. Horm Res 48 (Suppl 4):9–15
Ranke M.B. (ed) (1996) Diagnostics of endocrine function in children and adolescents, Edition J & J, Heidelberg
Rosenfeld R.G., Albertsson-Wikland K. et al. (1995) Diagnostic controversy: The diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 80: 1532–1540
Smith R.G., van der Ploeg L.H.T., Howard A.D. et al. (1997) Peptidomimetic regulation of growth hormone secretion. Endocrine Rev 18: 621–645
Thorner M.O., Bengtsson B.A., Ho K.Y. et al. (1995) Letter to the editor. The diagnosis of growth hormone deficiency in adults. J Clin Endocrinol Metab 80: 3097–3098
Wüster C., von zur Mühlen A., Ranke M.B. (1994) Das Syndrom des W.achstumshormonmangels beim Erwachsenen, Dtsch Arzteblatt 91: B–1795–B1796
Literatur zu Abschn. 7.7-7.2
Brämswig J., von Lengerke H.J., Schmidt H., Schellong G. (1988) The results of shortterm high-dose testosterone treatment on bone age and adult heigth in boys of excessively tall stature. Europ J Pediat 148: 104–106
Engström W.S., Lindharn S., Schofield P. (1988) WiedemannBeckwith syndrome. Europ J Pediat 147: 450–457
Gordon P., Corni R.J., Maton P.N., Go V.L.W. (1989) Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut. Ann Intern Med 110: 35–39
Jones K.L. (1994) The etiology and diagnosis of overgrowth syndromes. Growth Genetics Hormones 10: 6–10
Kaplan S.L., Grumbach M.M. (1990) Pathophysiology and treatment of sexual precocity. J Clin Endocrinol Metab 71:785–791
Moses A.E., Molitch M.E., Sawin C.T. (1981) Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effeet on serum levels of somatomedin C. J Clin Endocrinol Metab 53: 752–757
Mudd S.H., Skovby F., Levy H.L. (1985) The natural history of homocystinuria due to eystathionine-B-synthase deficiency. Am J Hum Genet 37: 1–7
Norman E.K., Tygstad O., Larsen S., Dahl-Jorgensen K. (1991) Height reduction in 539 tall girls treated with three different dosages of ethinyloestradial. Arch Dis Childh 66: 1275–1278
Plymate S.R.: Male hypogonadism. In: Becker K.L. (1995) Principles and praetice of endocrinology and metabolism. Lippincott, pp 1057–1082
Quabbe H.J., Müller O.A., Oelkers W., Willig R.P. (1993) Wachstumshormonexzess. In: Ziegler R., Pickardt C.R., Willig R.P. (eds) Rationelle Diagnostik in derEndokrinologie. Thieme, S9–10
Reinken L., von Oost G. (1992) Longitudianle Körperentwicklung gesunder Kinder von 0 bis 18 Jahren. Körperlänge,-höhe, Körpergewicht und Wachstumsgeschwindigkeit. Klin Pädiat 204: 129–133
Willig R.P., Bettendorf M., Hinkel G.K., Schwarz H.P., Schulze W. (1992) Androgen treatment of tall stature during puberty may reduce sperm quality in adult life. Hormone Res 37 (Suppl 4):3
Literatur zu Abschn. 7.4
Bengtsson B., Eden S., Ernest I., Oden A., Sjögren B. (1988) Epidemiology and long-term survival in aeromegaly. Acta Med Scand 233: 327–335
Clemmons D.R., van Wyk J.J., Redgeway E.C., Klima B., Kjellber R.N., Underwood L.E. (1979) Evaluation of acromegaly by radioimmunoassay of somatostatin C. New Engl J Med 301: 1138–1142
Faglio G., Arosio M., Bazzoni N. (1992) Ectopic acromegaly. Endocrinol Metab Clin North Am 21: 575–577
Fahlbusch R., Buchfelder M., Schrell U. (1985) Neurochirurgische Therapie neuroendokrinologischer Störungen. Internist 26: 293–301
Lamberts S.W., Reubi J.C., Krenning E.P. (1992) Somatostatin analogs in the treatment of acromegaly. Endocrinol Metab Clin North Am 21: 737–740
Losa M., Schopohl J., von Werder K. (1993) Ectopic secretion of growth hormone in man. J Endocr Invest 16: 69–81
Nyquist P., Laws E.R., Elliott R.N. (1994) Novel features oftumors that secrete both growth hormone and prolactin in acromegaly. Neurosurgery 35: 179–184
O’Duffy J.D., Randall R.V., MacCarry C.S. (1973) Median neuropathy (carpal tunnel syndrome in acromegaly. Ann Intern Med 78: 379–384
O’Sullivan A.J.. Kelly J.J., Hoffman D.M. (1994) Body composition and energy expenditure in acromegaly. J Clin Endocrinol Metab 78: 381–384
Plöckinger U., Dienemann D., Quabbe H. (1990) Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly. J Clin Endocr 71: 1658–1662
Quabbe H.J., Müller O.A., Oelkers W., Willig R.P. (1993) Wachstumshormonexzess. In: Ziegler R., Pickardt C.R., Willig R.P. (eds) Rationelle Diagnostik in derEndokrinologie. Thieme, S 9–10
Ross D.A., Wilson C.B. (1988) Results of transsphenoidal microsurgery for growth hormone secreting pituitary adenoma in aseries of 214 patients. J Neurosurg 68: 854–867
Savage D.D., Henry W.L., Easthman R.C. (1979) Echocardiographic assessment of cardiac anatomy and function in acromegalic patients. Am J Med 67: 823–827
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Binder, G., Haak, T., Ranke, M.B., Usadel, K.H. (2001). Wachstum. In: Nawroth, P.P., Ziegler, R. (eds) Klinische Endokrinologie und Stoffwechsel. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56784-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-56784-1_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62970-9
Online ISBN: 978-3-642-56784-1
eBook Packages: Springer Book Archive